<DOC>
	<DOCNO>NCT01868984</DOCNO>
	<brief_summary>The objective study evaluate safety effectiveness use intravascular paclitaxel , addition standard therapy , treatment arteriovenous dialysis access fistula stenosis . A fistulogram perform standard fashion . The diagnostic component include evaluation inflow artery , arterial anastomosis full length fistula vein graft , plus venous return heart . The location , vessel size , lesion diameter percent stenosis lesion record . Enrollment randomization occur point . All patient receive standard therapy stenosis . This include intravenous heparin administer standard dose 70 units/kg . Lesions respond poorly angioplasty ( &gt; 30 % residual stenosis angioplasty treatment 2 inflation ) stented . Stent selection base clinical setting . Initial stent treatment utilize uncovered nitinol stent . Treatment in-stent restenosis include initial balloon angioplasty , use cover stent ( Viabahn , GORE , Fluency , Bard ) . Documentation location type treatment lesion treat record . Once standard treatment complete , operate surgeon inform patient randomization : treatment ( paclitaxel ) control . For subject assign treatment , Paclitaxel solution treatment lesion encounter proximal distal attempt 20 mg Paclitaxel dose limit meet . A TAPAS infusion catheter use paclitaxel dose administration . The TAPAS infusion catheter position reduce presence branch permit loss paclitaxel treatment zone . After full outflow vein segment treat , fistulogram complete standard fashion . Prior removal sheath , final angiographic study area treat performed document patency lesion appearance . For control group , instead paclitaxel administration , sham treatment period 10 minute allow elapse follow performance final completion angiogram . Any additional lesion identify study treat appropriately follow standard technique . All patient follow follow evaluation schedule .</brief_summary>
	<brief_title>Paclitaxel Treatment Upper-Extremity Arteriovenous Access Fistula Stenosis</brief_title>
	<detailed_description />
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>1 . Age 18 year old 2 . Patient guardian able provide sign witness informed consent 3 . Stenosis great equal 50 % treat satisfactorily ( less 20 % residual stenosis ) balloon angioplasty alone balloon angioplasty stent placement 4 . Either gender 1 . Women pregnant expect might become pregnant 2 . Women childbearing potential use contraception 3 . Life expectancy le 12 month 4 . Known allergy paclitaxel 5 . Known allergy contrast medium previously demonstrate controllable premedication prior study use contrast 6 . Known allergy premedications ( dexamethasone , famotidine , diphenhydramine ) 7 . Prefistulogram thrombosis fistula graft 8 . Thrombectomy fistula graft within 14 day procedure 9 . Patient receive chemotherapy 10 . Patients immunodeficiency disease condition 11 . Documented hypercoagulable state 12 . White Blood Count &lt; 2000/mm3 13 . Platelet count less 100,000/mm3 14 . Chronic hepatitis jaundice ( total bilirubin &gt; 2x upper limit normal ) 15 . Simultaneous enrollment another investigational device drug study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>